A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent

Yıl: 2021 Cilt: 9 Sayı: 1 Sayfa Aralığı: 41 - 45 Metin Dili: İngilizce DOI: 10.14235/bas.galenos.2020.3966 İndeks Tarihi: 20-06-2021

A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent

Öz:
Objective: In this study, analysis of gemifloxacin in pharmaceutical preparations was performed in the presence of 4-bromomethyl-7-methoxycoumarin reagent and dibenzo-18-crown-6 ether catalyst, by high-performance liquid chromatography. Methods: The excitation wavelength of the compound formed as a result of the derivatization process was found as λext. =325 nm and the emission wavelength as λem. =390 nm. Optimum reaction conditions were carefully studied. Chromatographic separations were performed in a 150 cm x4.6 mm, 5 µm I.D C18 column, and the mobile phase consisting of acetonitrile: 0.05 M aqueous ammonium acetate (pH=5.0) (70:30, v/v) under flow rate of 1.0 mL/min.Results: The calibration curve was found to be linear in the range of 10-200 ng.mL-1. Average recovery was 100.32% and relative standard deviation values were below 2%.Conclusion: The method developed has been successfully applied in the analysis of the drug substance in pharmaceutical preparations.
Anahtar Kelime:

Gemifloksasinin 4-bromometil-7-metoksikumarin Belirteci Kullanılarak Farmasötik Preparatlarda HPLC ile Analizi

Öz:
Amaç: Bu çalışmada gemifloksasinin 4-bromometil-7- metoksikumarin belirteci ve dibenz-18-taç-6 eter katalizör varlığındafarmasötik preparatlarda yüksek performanslı sıvı kromatografisi ileanalizi gerçekleştirilmiştir. Yöntemler: Türevlendirme işlemi sonucu oluşan bileşiğin eksitasyondalga boyu λext. =325 nm ve emisyon dalga boyu λem. =390 nmolarak bulunmuştur. Optimum reaksiyon şartları dikkatlice çalışıldı.Kromatografik ayırmalar, 250x4,6 mm, 5 µm I.D C18 kolonda,asetonitril-0,05 M sulu amonyum asetat (pH=5,0) (70:30, v/v)mobil fazında, 1 mL/dak akış hızında gerçekleştirilmiştir. Bulgular: Kalibrasyon eğrisi 10-200 ng.mL-1 aralığında doğrusalbulunmuştur. Ortalama geri kazanım %100,32 ve bağıl standartsapma değerleri %2’nin altında bulunmuştur. Sonuç: Geliştirilen metod, ilaç maddesin farmasötik preparatlardakianalizine başarıyla uygulanmştır.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Budavari S. The Merck Index,Merck and Co. Whitehouse Station, NJ, USA: 13th ed, 2001.
  • 2. Völgyi G, Vizserálek G, Takács-Novák K, Avdeef A, Tam KY. Predicting the exposure and antibacterial activity of fluoroquinolones based on physicochemical properties. Eu J Pharm Sci 2012;47:21-7.
  • 3. Oh JI, Paek KS, Ahn MJ, Kim MY, Hong CY, Kim IC, et al. In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone. Antimicrob Agents Chemother 1996;40:1564-8.
  • 4. Hohl AF, Frei R, Punter V, Graevenitz A, Knapp C, Washington J, et al. International multicenter investigation of LB20304, a new fluoronaphthyridone. Clin Microbiol Infect 1998;4:280-4.
  • 5. Kepekci Tekkeli SE, Önal A. Spectrofluorimetric methods for the determination of gemifloxacin in tablets and spiked plasma samples. J Fluoresc 2011;21:1001-7.
  • 6. Youssef NF, Bebawy LI. Spectrofluorimetric methods for the determination of gemifloxacin mesylate and cefamandole nafate in bulk powder and pharmaceutical preparations. Bulletin of the Faculty of Pharmacy 2006;44:215-27.
  • 7. Rote AR, Pingle SP. Reverse phase-HPLC and HPTLC methods for determination of gemifloxacin mesylate in human plasma. J Chromatogr B 2009;877:3719-23.
  • 8. Al-Hadiya BM, Khady AA, Mostafa GA. Validated liquid chromatographic-fluorescence method for the Quantitation of gemifloxacinin human plasma. Talanta 2010;83:110-6.
  • 9. Kaiser M, Grünspan LD, Costa TD, Tasso L. Reversed phase liquid chromatography method with fluorescence detection of gemifloxacin in rat plasma and its application to the pharmacokinetic study. J Chromatogr B 2011;879:3639-44.
  • 10. Nageswara RR, Naidu ChG, Guru PK, Padiya R, Agwane SB. Determination of gemifloxacin on dried blood spots by hydrophilic interaction liquid chromatography with fluorescence detector: application to pharmacokinetics in rats. Biomed Chromatogr 2012;26:1534-42.
  • 11. Doyle E, Fowles SE, McDonnell DF, White SA Rapid determination of gemifloxacin in human plasma by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B 2000:746:191-8.
  • 12. Radi AE, Khafagy A, El-Shobaky A, El-Mezayen H. Anodic Voltammetric determination of gemifloxacin using screenprinted carbon electrode J Pharm Anal 2013;3:132-6.
  • 13. Elbashir, AA. Saad, B.. Ali, ASM, Al-Azzam, KMM, Aboul-Enein HY, Validated stability indicating assay of gemifloxacin and lomefloxacin in tablet formulations by capillary electrophoresis J Liq Chromatogr Relat Technol 2008;31:1465-77.
  • 14. Zacharis CK, Raikos N, Giouvalakis N, Tsoukali-Papadopoulou H, Theodoridis GA. A new method for the HPLC determination of gamma-hydroxybutyric acid (GHB) following derivatization with a coumarin analogue and fluorescence detection: application in the analysis of biological fluids. Talanta 2008;75:356-61.
  • 15. Hulshoff A, Förch AD. Alkylation with alkylhalides as a derivatization method for the gas chromatographic determination of acidic pharmaceuticals. J Chromatogr 1981;220:275-311.
  • 16. Wang K, Nano M, Mulligan T, Bush ED, Edom RW. Derivatization of 5-fluorouracil with 4-bromomethyl-7-methoxycoumarin for determination by liquid chromatography-mass spectrometry. J Am Soc Mass Spectrom 1998;9:970-6.
  • 17. ICH, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Text and Methodology Q2 (R1), 2005.
APA Önal C (2021). A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent. , 41 - 45. 10.14235/bas.galenos.2020.3966
Chicago Önal Cem A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent. (2021): 41 - 45. 10.14235/bas.galenos.2020.3966
MLA Önal Cem A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent. , 2021, ss.41 - 45. 10.14235/bas.galenos.2020.3966
AMA Önal C A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent. . 2021; 41 - 45. 10.14235/bas.galenos.2020.3966
Vancouver Önal C A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent. . 2021; 41 - 45. 10.14235/bas.galenos.2020.3966
IEEE Önal C "A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent." , ss.41 - 45, 2021. 10.14235/bas.galenos.2020.3966
ISNAD Önal, Cem. "A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent". (2021), 41-45. https://doi.org/10.14235/bas.galenos.2020.3966
APA Önal C (2021). A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent. Bezmiâlem Science, 9(1), 41 - 45. 10.14235/bas.galenos.2020.3966
Chicago Önal Cem A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent. Bezmiâlem Science 9, no.1 (2021): 41 - 45. 10.14235/bas.galenos.2020.3966
MLA Önal Cem A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent. Bezmiâlem Science, vol.9, no.1, 2021, ss.41 - 45. 10.14235/bas.galenos.2020.3966
AMA Önal C A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent. Bezmiâlem Science. 2021; 9(1): 41 - 45. 10.14235/bas.galenos.2020.3966
Vancouver Önal C A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent. Bezmiâlem Science. 2021; 9(1): 41 - 45. 10.14235/bas.galenos.2020.3966
IEEE Önal C "A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent." Bezmiâlem Science, 9, ss.41 - 45, 2021. 10.14235/bas.galenos.2020.3966
ISNAD Önal, Cem. "A Liquid Chromatographic Analysis of Gemifloxacin inPharmaceutical Preparations Using 4-bromomethyl-7- methoxycoumarin Reagent". Bezmiâlem Science 9/1 (2021), 41-45. https://doi.org/10.14235/bas.galenos.2020.3966